
Vasitimb®, the new ezetimibe + simvastatin combination, has just been launched
April 10, 2019
1st globally, Pharmazac launches generic sugammadex
September 7, 2020Pharmazac launches Apregalin® (pregabalin)

Pharmazac launches the new product Apregalin® (pregabalin) for the treatment of peripheral and central neuropathic pain in adults, for epilepsy as adjunctive therapy in adults with partial seizures with or without secondary generalization and for the Generalized Anxiety Disorder in adults.
Related News
November 4, 2026
Pharmazac at MPRAD 2026: Advancing Cardiac Imaging
The “3rd Panhellenic Conference of Medical Physics & 27th Inter-University Conference of Radiology”, held on 30–31 October and 1 November at the University of Thessaly in […]
October 12, 2026
Pharmazac, strong in Contract Development and Manufacturing Services
Pharmazac was delighted to be featured in the “Health” supplement of the prestigious newspaper “TO VIMA” on Sunday, October 11. Through an advertorial highlighting its participation […]
October 8, 2026
Pharmazac maintained a strong presence at CPhI 2026
Marking forty years in the pharmaceutical market this year, Pharmazac chose to celebrate the milestone with an even more dynamic presence at the international Convention on […]
September 26, 2026
Anniversary feature in KATHIMERINI’s “Golden Anniversaries”
We are honoured to be featured in “Golden Anniversaries 2026”, a special supplement by ICAP CRIF published with KATHIMERINI on 26 September 2026. The edition celebrates […]
